1. Home
  2. MYGN vs OI Comparison

MYGN vs OI Comparison

Compare MYGN & OI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Myriad Genetics Inc.

MYGN

Myriad Genetics Inc.

N/A

Current Price

$6.31

Market Cap

625.5M

Sector

Health Care

ML Signal

N/A

Logo O-I Glass Inc.

OI

O-I Glass Inc.

N/A

Current Price

$15.00

Market Cap

2.0B

ML Signal

N/A

Company Overview

Basic Information
Metric
MYGN
OI
Founded
1991
1903
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Containers/Packaging
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
625.5M
2.0B
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
MYGN
OI
Price
$6.31
$15.00
Analyst Decision
Buy
Buy
Analyst Count
12
7
Target Price
$11.82
$16.29
AVG Volume (30 Days)
921.9K
2.3M
Earning Date
11-03-2025
02-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$825,300,000.00
$6,455,000,000.00
Revenue This Year
$0.08
$1.41
Revenue Next Year
$5.28
$1.99
P/E Ratio
N/A
N/A
Revenue Growth
0.21
N/A
52 Week Low
$3.76
$9.23
52 Week High
$15.47
$16.04

Technical Indicators

Market Signals
Indicator
MYGN
OI
Relative Strength Index (RSI) 36.30 60.95
Support Level $6.38 $14.81
Resistance Level $6.89 $15.09
Average True Range (ATR) 0.27 0.35
MACD -0.07 -0.07
Stochastic Oscillator 2.90 52.66

Price Performance

Historical Comparison
MYGN
OI

About MYGN Myriad Genetics Inc.

Myriad Genetics Inc is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel capable of identifying the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm also offers pharma and biotech companies biomarker discovery and companion diagnostic services.

About OI O-I Glass Inc.

O-I Glass is the world's largest manufacturer of glass bottles; 70% of its revenue comes from outside the United States. O-I has a leading position in key markets such as Europe, North America, and Brazil. Beer is the primary end market for O-I's glass bottles, which are also used for wine, soda, spirits, condiments, and food. O-I is looking to maintain or expand its dominant positions in Europe, North America, and South America.

Share on Social Networks: